🧪 Hypotheses

combination 0.00

LDLR-Primed LRP1 Transcytosis with pH-Responsive Escape Strategy

🧬 LDLR 🏥 neuropharmacology 📖 15🏛 1

✅ 0.00 ✨ 0.00 💥 0.00

This strategy combines targeted upregulation of LDLR expression in brain endothelial cells with engineered antibodies designed for LRP1-mediated trans...

combination 0.00

LDLR-Mediated Neurosteroid Precursor Delivery Strategy

🧬 LDLR 🏥 neuropharmacology 📖 15🏛 1

✅ 0.00 ✨ 0.00 💥 0.00

The LDLR-Mediated Neurosteroid Precursor Delivery Strategy proposes utilizing the low-density lipoprotein receptor (LDLR) not for antibody transport, ...

combination 0.00

GLUT1-Mediated Carrier-Conjugate Delivery Strategy

🧬 LDLR 🏥 neuropharmacology 📖 15🏛 1

✅ 0.00 ✨ 0.00 💥 0.00

The GLUT1-Mediated Carrier-Conjugate Delivery Strategy proposes that therapeutic antibody delivery to the CNS can be optimized by targeting the glucos...

unknown 0.66

Parthenolide reduces tonic ADORA2A signaling by lowering inflammatory extracellular adenosine tone

🧬 ADORA2A 🏥 neuropharmacology 📖 6🏛 1

✅ 0.74 ✨ 0.64 💥 0.66

NF-kB suppression in glia decreases ectonucleotidase and cytokine programs that sustain extracellular adenosine, indirectly reducing ADORA2A pathway o...

combination 0.58

FcRn Transport Bypass Strategy

🧬 LDLR 🏥 neuropharmacology 📖 15🏛 1

✅ 0.70 ✨ 0.40 💥 0.80

## Mechanistic Overview...

therapeutic 0.55

MFSD2A-Targeted Lysophosphatidylcholine-SPM Conjugates as CNS-Penetrant Pro-Resolving Prodrugs

🧬 MFSD2A (SLC59A1) 🏥 neuropharmacology 📖 15🏛 1

✅ 0.35 ✨ 0.85 💥 0.72

## Mechanistic Overview...

combination 0.52

LRP1-Mediated Endosomal Escape Enhancement Strategy

🧬 LDLR 🏥 neuropharmacology 📖 15🏛 1

✅ 0.00 ✨ 0.00 💥 0.00

The LRP1-Mediated Endosomal Escape Enhancement Strategy proposes that therapeutic antibody delivery to the CNS can be optimized by targeting the low-d...

unknown 0.51

Parthenolide perturbs adenosine transport or metabolism upstream of ADORA2A

🧬 ADORA2A 🏥 neuropharmacology 📖 1🏛 1

✅ 0.61 ✨ 0.67 💥 0.55

Covalent modulation of transporters or metabolic enzymes changes local receptor occupancy in a context-dependent manner.

combination 0.50

SIRT1-Mediated Epigenetic Restoration of MFSD2A Expression Re-enables SPM Precursor Transport in Aged BBB

🧬 MFSD2A / SIRT1 (deacetylase activator axis) 🏥 neuropharmacology 📖 12🏛 1

✅ 0.30 ✨ 0.65 💥 0.58

## Mechanistic Overview...

combination 0.50

LDLR-Targeted Anti-Inflammatory Antibody Delivery for Neuroinflammation Suppression

🧬 LDLR 🏥 neuropharmacology 📖 15🏛 1

✅ 0.00 ✨ 0.00 💥 0.00

This hypothesis proposes engineering therapeutic antibodies with dual functionality: LDLR-binding domains for CNS penetration coupled to anti-inflamma...

unknown 0.48

Parthenolide enhances ADORA2A receptor internalization through direct sesquiterpene lactone-mediated cysteine modificati

🧬 ADORA2A 🏥 neuropharmacology 📖 6🏛 1

✅ 0.00 ✨ 0.00 💥 0.00

Parthenolide directly targets ADORA2A receptors through its reactive sesquiterpene lactone moiety, which forms covalent Michael adducts with specific ...

unknown 0.44

Parthenolide changes ADORA2A coupling efficiency through membrane microdomain remodeling

🧬 ADORA2A 🏥 neuropharmacology 📖 0🏛 1

✅ 0.50 ✨ 0.76 💥 0.49

The scaffold alters receptor signaling efficacy without strong orthosteric affinity by modifying redox-sensitive lipid nanodomains.

combination 0.38

LDLR-Mediated Lipid Carrier Neurotherapeutic Delivery

🧬 LDLR 🏥 neuropharmacology 📖 15🏛 1

✅ 0.00 ✨ 0.00 💥 0.00

## Mechanistic Overview...

combination 0.38

RAGE-Mediated Transcytotic Pump Enhancement Strategy

🧬 LDLR 🏥 neuropharmacology 📖 15🏛 1

✅ 0.00 ✨ 0.00 💥 0.00

The RAGE-Mediated Transcytotic Pump Enhancement Strategy proposes that therapeutic antibody delivery to the CNS can be optimized by targeting the rece...

combination 0.38

LDLR-Mediated Neuroinflammation Modulation Strategy

🧬 LDLR 🏥 neuropharmacology 📖 15🏛 1

✅ 0.00 ✨ 0.00 💥 0.00

The LDLR-Mediated Neuroinflammation Modulation Strategy proposes that direct pharmacological enhancement of LDLR expression and activity within brain ...

combination 0.38

LDLR-Primed LRP1 Transcytosis with pH-Activated Endosomal Escape

🧬 LDLR 🏥 neuropharmacology 📖 15🏛 1

✅ 0.00 ✨ 0.00 💥 0.00

This strategy combines LDLR upregulation in brain endothelial cells with engineered LRP1-targeting antibodies containing pH-responsive endosomal escap...

combination 0.38

LDLR-Mediated Reverse Cholesterol Transport Modulation for CNS Drug Delivery

🧬 LDLR 🏥 neuropharmacology 📖 15🏛 1

✅ 0.00 ✨ 0.00 💥 0.00

The LDLR-Mediated Reverse Cholesterol Transport Modulation strategy proposes that CNS drug delivery can be enhanced by hijacking the LDLR-dependent re...

combination 0.38

LDLR-Primed LRP1 Transcytosis with Endosomal Liberation Strategy

🧬 LDLR 🏥 neuropharmacology 📖 15🏛 1

✅ 0.00 ✨ 0.00 💥 0.00

This strategy combines LDLR upregulation-mediated cholesterol transport machinery priming with engineered endosomal escape mechanisms to achieve super...